EUVIMEDEUVIMED entdecken
Systematische Übersicht

Efficacy and safety of calcium channel blockers in migraine management; a systematic review

Hamed Ghiami, Mohammadsalman Parsapour, Sahba Khalilzadeh, Hanieh Rahmani, Navid Omidkhoda, Omid Arasteh

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04422-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Hamed Ghiami und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Damghan Branch, Islamic Azad University, Damghan, Iran. Hauptthemen laut MEDLINE: Migraine Disorders, Calcium Channel Blockers. Die Arbeit nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Numerous innovative treatment approaches have been developed to treat migraine, one of the most upsetting disorders. However, the optimal strategy for managing migraines remains unclear. The calcium channel blockers have demonstrated some positive effects on migraine attacks. In this systematic review, we tried to gather data on the efficacy and safety of these drugs to reach a more precise conclusion. METHOD: The databases of PubMed, Scopus and Web of Science were searched systematically up to 1 August 2024. The risk of bias was assessed for clinical trials through the Cochrane Collaboration's tool. RESULTS: Out of 1903 studies, we included 40 clinical trials. Among 27 studies on flunarizine (FLU), most of them showed significantly superior effects in comparison with placebo or other agents. Sedation and weight gain were the most prevalent side effects experienced by FLU. Although three studies demonstrated positive effects of nimodipine (NIM) in migraine management, the seven remaining studies revealed controversial results. Three and one articles evaluating the efficacy and safety of nifedipine (NIF) and verapamil (VER) to other drugs, respectively, reported no special effects. CONCLUSION: According to reviewed research, FLU appears to have the greatest impact on migraine episodes, whereas NIM outperforms B blockers in terms of migraine prevention. Further study is necessary to get more precise data on NIF and VER.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersCalcium Channel BlockersHumansFlunarizineTreatment Outcome

Stichwörter der Autor:innen

CCBsCalcium Channel BlockersFlunarizineMigraineNimodipine

Substanzen

Calcium Channel BlockersFlunarizine

Autor:innen und Institutionen

  • Department of Pharmacy, Damghan Branch, Islamic Azad University, Damghan, Iran.
  • Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Navid.omidkhoda1991@gmail.com.
  • Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. ArastehO@mums.ac.ir.

Zitieren

APA

Ghiami, H., Parsapour, M., Khalilzadeh, S., Rahmani, H., Omidkhoda, N., & Arasteh, O. (2025). Efficacy and safety of calcium channel blockers in migraine management; a systematic review. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04422-2

Vancouver

Ghiami H, Parsapour M, Khalilzadeh S, Rahmani H, Omidkhoda N, Arasteh O. Efficacy and safety of calcium channel blockers in migraine management; a systematic review. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04422-2

BibTeX
@article{Ghiami2025,
  author = {Ghiami, Hamed and Parsapour, Mohammadsalman and Khalilzadeh, Sahba and Rahmani, Hanieh and Omidkhoda, Navid and Arasteh, Omid},
  title = {Efficacy and safety of calcium channel blockers in migraine management; a systematic review},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04422-2}
}
Kostenlos starten →